lincRNA-p21 inhibits foam cell formation and regulates cholesterol uptake and efflux in macrophages through the PKCδ/Akt/Erk and PPARγ/LXRα pathways
General physiology and biophysics · 2026
DOI: 10.4149/gpb_2025040 ↗Kurz gefasst
Fachartikel in der Zeitschrift General physiology and biophysics, 2026. Verfasst von Chao He und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Cardiology, China Three Gorges University, Yichang, Hubei, P.R. China. Hauptthemen laut MEDLINE: Foam Cells, Cholesterol, PPAR gamma, RNA, Long Noncoding. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Impairment in cholesterol uptake and efflux is the main reason contributing to foam cell formation, which is a marker and key step in the atherosclerotic process. Overexpression of long intergenic non-coding RNA-p21 (lincRNA-p21) was reported to alleviate the development of atherosclerosis. However, whether lincRNA-p21 exerts an antiatherogenic function by alleviating lipid metabolism dysfunction and foam cell formation remains unknown. In our study, human THP-1 monocytes were stimulated for 48 h by phorbol 12-myristate-13-acetate (PMA) to differentiate into macrophages, and THP-1-derived macrophages were further treated for 24 h with oxidized low-density lipoprotein (ox-LDL) to differentiate into foam cells. THP‑1 macrophage-derived foam cells were transfected with si-NC/si-lincRNA-p21 or LV-NC/LV-lincRNA-p21 for 48 h to knock down or overexpress lincRNA-p21. lincRNA-p21 expression was reduced in THP-1-derived macrophages after ox-LDL treatment. lincRNA-p21 knockdown promoted lipid uptake and accumulation and inhibited cholesterol efflux in ox-LDL-treated THP-1 macrophages, while lincRNA-p21 overexpression exerted an opposite effect on cholesterol influx and efflux. Importantly, lincRNA-p21 attenuated cholesterol influx by suppressing the PKCδ/Akt/Erk/SR-A/CD36 pathway and enhanced cholesterol efflux by promoting the PPARγ/LXRα/ABCA1/ABCG1 pathway in foam cells derived from THP-1 macrophages.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute of Cardiology, China Three Gorges University, Yichang, Hubei, P.R. China.
Zitieren
APA
He, C., Yang, W., Zhou, F., Teng, L., Wu, H., Guo, Z., Ding, J., Zhang, J., Yang, J., & Li, S. (2026). lincRNA-p21 inhibits foam cell formation and regulates cholesterol uptake and efflux in macrophages through the PKCδ/Akt/Erk and PPARγ/LXRα pathways. General physiology and biophysics. https://doi.org/10.4149/gpb_2025040
Vancouver
He C, Yang W, Zhou F, Teng L, Wu H, Guo Z, et al. lincRNA-p21 inhibits foam cell formation and regulates cholesterol uptake and efflux in macrophages through the PKCδ/Akt/Erk and PPARγ/LXRα pathways. General physiology and biophysics. 2026. doi:10.4149/gpb_2025040
BibTeX
@article{He2026,
author = {He, Chao and Yang, Wei and Zhou, Fei and Teng, Lin and Wu, Hui and Guo, Zhuli and Ding, Jiawang and Zhang, Jing and Yang, Jian and Li, Song},
title = {lincRNA-p21 inhibits foam cell formation and regulates cholesterol uptake and efflux in macrophages through the PKCδ/Akt/Erk and PPARγ/LXRα pathways},
journal = {General physiology and biophysics},
year = {2026},
doi = {10.4149/gpb_2025040}
}
EUVIMED